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1 Tbc affinities of the (R)- and (S)-enantiomers of hexahydro-difenidol (1) and its acetylenie analogues 
hexbutinol (2), hexbutinol methiodide (3) and p-fluoro-hexbutinol (4) (stereochemieal purity > 99.8%) for 
musearlnie receptors in rabbit vas deferens (M 1), guinea-pig atria (M 2) and guinea-pig ileum (M 3) were 
measured by dose-ratio experiments. 
2 The (R)-enantiomers consistently showed higher aßinities than the (S)-isomers. The stereosclectivity 
ratios [(R)/(S)] wcrc greatest with thc enantiomers of 1 (vas deferens: 550; ilcum: 191; atria: 17) and least 
with thosc ofthc p-Fluoro-analogue 4 (vas defercns: 34; ileum: 8.5; atria: 1.7). 
3 The enantiomerie potency ratios for compounds 1-4 were highest in rabbit vas deferens, intermediate 
in guinea-pig ileum and much less in guinea-pig atria. Thus, these ratios may serve as a predietor of 
muscarinic receptor subtype identity. 
4 (S)-p-Fluoro-hexbutinol [(S)-4] showed a novel receptor selectivity profile with preference for M 3 
receptors: M3 > M 2 ~ M 1• 
5 These results do not conform to Pfeiffer's rule that aetivity differences between enantiomers are greater 
with more potent compounds. 
lntroduction 
A large body of evidence derived from both functional and 
radioligand binding studies suggests that there are at least 
three pharmacological musearlnie receptor subtypes [M., M2 
(M2J and M3 (M21)] (Eglen & Whiting, 1986; Mitehelson, 
1988; Giraldo et al., 1988; Waelbroeck et al., 1988a; 1989; 
Lambrecht et al., 1989d). This subclassification was recently 
confirmed by cloning, sequencing and expression of comple-
mcntary DNA encoding five musearlnie receptors (m1-m5) 
(Kerlavage et al., 1987; Peralta et al., 1987; Akiba et al., 1988; 
Brann et al., 1988). The antagonist binding properties of 
m1-m3 and their patterns of expression in various tissues 
eloscly correspond to thosc of the M 1, M 2 and M 3 r,eceptors 
(Peralta et al., 1987; Akiba et al., 1988; Maeda et al., 1988; 
Buekley et al., 1989). Tbc selective muscarinic antagonists 
pirenzepinc (Hammer et al., 1980; Lambrecht et al., 1988a; 
Waelbroeck et al., 1988a; 1989), methoetramine (Melchiorre et 
al., 1987; Wess et al., 1988), AF-DX 116 (Giachetti et al., 
1986), hexahydro-(sila-)difenidol (Mutschler & Lambrecht, 
1984; Lambrecht et al., 1988a; 1989d; Waelbroeck et al., 
1988a; 1989; Akiba et al., 1988; Buekley et al., 1989) and p-
fluoro-hexahydro-sila-difenidol (Lambrecht et al., 1988a; 
1989b,d) have proved to be useful tools in this sub-
elassifieation. 
Among tbese selective musearlnie antagonists, racemie 
hexahydr<Hiifenidol ((RfS)-1; Figure 1] has been shown to 
have high affinity for M1 receptors in neuronal tissues as well 
as for M 3 receptors in exoerine glands and smooth muscles, 
but a mueh lower affinity for cardiac M2 receptors (Mutschler 
& Lambrecht, 1984; Eltze et al., 1988; Lambrecht et al., 
1988c; Waelbroeck et al., 1989). The main aim of the present 
study was to cbaracterize the structural demands, including 
stereochemical aspects, for potency and selectivity of some 
chiral acetylenic analogues of hexahydro-difenidol (J) (Figure 
1). Since a conformationally rigid acetylenic moiety is present 
in some selective musearlnie agonists such as MeN-A-343 
(Roszkowski, 1961; Lambrecht et al., 1986; Eltze et al., 1988; 
1 Author for correspondence. 
Wesset al., 1988) and arecaidine propargyl ester (Mutschler & 
Hultzseh, 1973; Mutschier & Lambrecht, 1984; Moser et al., 
1989), it would be of interest to investigate whether the acety-
lenic analogues of hexahydro-difenidol are also selective for 
muscarinic receptor subtypes. 
In the last few years, data have accumulated that musear-
inic receptors ean be differentiated on the basis of thcir stereo-
selectivity to chirat antagonists such as procyelidine 
(Lambrecht & Mutschler, 1986; Taeke et al., 1986; Wael-
broeck et al., 1988b), trihexyphenidyl (Lambrecht et al., 1988b; 
1989d), phenglutarimide (Lambrecht et al., 1989a), biperiden 
(Eltze & Figala, 1988) and telenzepine (Eveleigh et al., 1989). 
Hexahydro-difenidol (J) and its analogues bexbutinol (2), hex-
butinol methiodide (3) and p-fluoro-hexbutinol (4) (Figure 1) 
possess a centre of chirality and therefore exist in two enantio-
mers. We took advantage of this by determining the antago-
nist affinities of the individual enantiomers of these 
compounds at musearlnie receptor subtypes. The results were 
eompared with those obtained for the selective reference drugs 
hexahydro-sila-difenidol (M3 ~ M 1 > M 2) and p-tluoro-
hexahydro-sila-difenidol (M3 > M 1 > M 2). The receptors 
studied were presynaptic M1 heteroreceptors in rabbit vas 
deferens (Eltze, 1988; Eltze et al., 1988; Lambrecbt et al., 
1988a,b), cardiac M2 receptors present in guinea-pig atria and 
smooth muscle M3 receptors present in guinea-pig ileum. 
Some of the present results have been briefly presented else-
where (Feifel et al., 1988; Lambrecht et al., 1989e; Tacke et al., 
1989). 
Metbods 
Rahbit isolated vas deferens 
Experiments on rabbit isolated vas deferens were carried out 
according to Eltze (1988) and Eltze et al. (1988). Male New 
Zealand white rabbits (2.5-J.Okg) were killed by i.v. injection 
of 120 mg kg- 1 pentobarbitone sodium. V asa dcferentia were 
excised, dissected free of connective tissues and divided into 
four segments of approximately 1.5 cm length. The prep-
arations were sct up in 7 m1 organ baths containing modified 
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Figure 1 Chemical structures of the enantiomers of hexahydro-
difenidol (/), hexbutinol (2), hexbutinol methiodide (3) and p-fluoro-
hexbutinol (4). The asterisk denotes the centre of chirality. 
Krebs buffer which consisted of (mM): NaCI 118.0, KCI 4.7, 
CaCI2 2.5, MgS04 0.6, KH2P04 1.2, NaHC03 25.0 and ( + )-
glucose 11.1 ; 1 JLM yohimbine was included to block 
oc2-adrenoceptors. The bathing fluid was maintained at 31°C 
and aerated with 95% 0 2/5% C02 • A basal tension of 750mg 
was applied and after a 30 min period of initial equilibration 
isometric twitch contractions were elicited by electrical field 
stimulation (0.05 Hz, 0.5 ms, 30 V) with platinum electrodes. 
The contractions were measured isometrically by a force-
displacement transducer connected to a Heilige amplifier and 
a Rikadenki polygraph. These effects were concentration-
dependently inhibited by the M 1 receptor agonist 4-(4-chlo-
rophenylcarbamoyloxy)-2-butynyltrimethylammonium iodide 
(4-Cl-McN-A-343) (Eltze et al., 1988). 
Guinea-pig isolated left atria and ileallongitudinal muscle 
Guinea-pigs (3ro-400 g) of either sex were killed by cervical 
dislocation. The organs required were removed and set up in 
6ml organ baths, under 500mg tension, in oxygenated (95% 
0 2/5% C02) Tyrode solution (32°C) composed of (mM): NaCl 
137.0, KCl 2.7, CaC12 1.8, MgC12 1.05, NaHC03 11.9, 
NaH2P04 0.42 and ( + )-glucose 5.6. Arecaidine propargyl 
ester (Mutschler & Hultzsch, 1973; Mutschier & Lambrecht, 
1984; Moser et al., 1989) was used as an agonist. Left atria 
were paced electrically (2 Hz, 3 ms, 5 V) by means of platinum 
electrodes. Negative inotropic effects to the agonist were mea-
sured as changes in isometric tension. Responses of ileal longi-
tudinal muscle strips (Paton & Zar, 1968) to arecaidine 
propargyl ester were measured as isotonic contractions. The 
effects in atria and ileum were recorded as with the rabbit 
isolated vas deferens. 
Antagonist affinities 
After a 1 h equilibration period, concentration-response curves 
were constructed by adding doses of the agonists cumula-
tively, according to the method of Van Rossum (1963). When 
these responses were constant, concentration-response curves 
were repeated in the presence of antagonists. At least three 
concentrations of antagonists with log intervals of 0.5 were 
tested 3 to 5 times (see Table 1) in the three tissues. Each 
concentration of antagonist was allowed to equilibrate for 15 
to 30min (ileum) and 30min (atrium) in guinea-pig prep-
arations, respectively, and 30 [(S)-isomers] to 60min [(R)-
isomers] in rabbit vas deferens. Preliminary experiments indi-
cated that these intervals were sufficient for equilibration of 
the antagonist concentrations used. No preparation was 
exposed to more than three concentrations of antagonists. 
EC50 values of agonists in the absence and presence of 
antagonists were determined graphically for calculation of 
dose-ratios. The slopes of the Arunlakshana-Schild plots 
(Arunlakshana & Schild, 1959) were determined by linear 
regression by the method of least squares. pA2 values were 
estimated as the intercept on the abscissa scale by fitting to 
the data the best straight line with a slope of unity (Tallarida 
et al., 1979). 
Data analysis 
All data are presented as means ± s.e.mean of 9-17 experi-
ments. Differences between mean values were tested for sta-
tistical significance by Student's t test; P < 0.05 was accepted 
as being significant. Linear regression analyses were carried 
out by the method of least squares (Tallarida et al., 1979). 
Drugs 
Pirenzepine dihydrochloride was obtained from Boehringer 
lngelheim (F.R.G.). 4-(4-Chlorophenylcarbamoyloxy)-2-
butynyltrimethylammonium iodide (4-Cl-McN-A-343) 
(Nelson et al., 1976), arecaidine propargyl ester (Mutschler & 
Hultzsch, 1973), racemic hexahydro-sila-difenidol hydro-
chloride (Tacke et al., 1985), (R)- and (S)-hexahydro-difenidol 
hydrochloride [(R)-1· HO and (S)-J· HCl] (Tacke et al., 
1989) as weil as (R)- and (S)-bexbutinol [(R)-2 and (S)-2] 
(Tacke et al., 1989) were synthesized in our laboratories 
according to tbe literature. The enantiomeric excess (ee) of the 
enantiomers of bexabydro-difenidol and bexbutinol was 
>99.8%, determined by calorimetric analysis as described by 
Tacke et al. (1987). Racemic p-ftuoro-hexahydro-sila-difenidol 
hydrochloride was prepared by analogy to the synthesis of 
hexahydro-sila-difenidol (Tacke et al., unpublished results). 
The enantiomers of p-ftuoro-hexbutinol [(R)-4 and (S)-4; 
enantiomeric purity: ee > 99.8%; calorimetric analysis] were 
synthesized by analogy to (R)- and (S)-hexbutinol (Tacke et 
al., 1989). The other chemieals not described under 'Synthetic 
chemistry' were of reagent grade and were used as purchased. 
Synthetic chemistry 
The enantiomers of hexbutinol methiodide [(R)-3 and (S)-3] 
were prepared as follows: 
Freshly distilled methyl iodide (18 mmol) was added under 
an atmosphere of dried nitrogen to a solution of (R)- or (S)-
hexbutinol {2) (8mmol) in dry ethanol (50ml). The reaction 
mixturewas stirred for 3 hat 30°C, dry n-pentane (100ml) was 
added, and the mixture was stirred for 1 h at 20°C. Thereafter, 
the precipitate was collected by filtration and then recry-
TableI pAz values and slopes of Arunlakshana-Schild 
plots (in parentheses) for musearlnie antagonists at M 1, Mz 
and M 3 receptors 
Rabbit vas Guinea-pig 
Compound deferens (M 1) atria (Mz) 
HHSiD• 7.92 ± 0.07 6.53 ± 0.05 
p-F-HHSiD• 6.68 ± 0.12 6.01 ± 0.06 
Hexahydro-difenidol (1) 
(R)-1 8.71 ± 0.05 7.03 ± 0.06" 
[n=-17;6] [n = 9; 8] 
(1.26 ± 0.09)* (0.83 ± 0.30) 
(S)-1 5.97 ± 0.04 5.80 ± 0.07" 
[n = 13; 9] [n = 9; 8] 
(0.87 ± 0.10) (0.96 ± 0.19) 
Hexbutinol (2) 
(R)-2 8.78 ± 0.05 7.77 ± 0.04" 
[n = 13; 6] [n = 10; 10] 
(1.16 ± 0.11) (1.09 ± 0.07) 
(S)-2 6.75 ± 0.07 6.84 ± 0.05" 
[n=17;8] [n = 9; 9] 
(0.84 ± 0.1 5) ( 1.03 ± 0.13) 
Hexbutinol methiodide (3) 
(R)-3 9.43 ± 0.06 8.62 ± 0.02 
[n = 9; 5] [n = 13; 13] 
(0.92 ± 0.11) ( 1.07 ± 0.03) 
(S)-3 7.83 ± 0.05 7.40 ± 0.02 
[n = 12; 4] [n = 12; 4] 
(0.92 ± 0.07) (0.91 ± 0.04) 
p-Fluoro-hexbutinol (4) 
(R)-4 8.08 ± 0.06 6.97 ± 0.04 
[n = 13; 5] [n = 12; 12] 
(1.31 ± 0.10)* (0.84 ± 0.06) 
(S)-4 6.55 ± 0.08 6.75 ± 0.05 
[n = 17; 6] [n = 9; 9] 
(0.85 ± 0.18) (1.03 ± 0.09) 
• Data taken from Lambrccht et al. (1988a). 
"Data taken from Tacke et al. (1989). 
Guinea-pig 
Ileum (M 3) 
7.96 ± 0.03 
7.84 ± 0.03 
8.35 ± 0.04" 
[n = 14; 11] 
(0.92 ± 0.07) 
6.07 ± 0.05" 
[n = 9; 6] 
(0.87 ± 0.17) 
8.78 ± 0.04" 
[n = 13; 10] 
(1.10 ± 0.06) 
7.14 ± 0.04" 
[n = 10; 5] 
(0.99 ± 0.07) 
8.85 ± 0.04 
[n = 17; 16] 
(1.14 ± 0.06) 
7.26 ± 0.02 
[n = 12; 7] 
(0.96 ± 0.03) 
8.50 ± 0.04 
[n = 16; 8] 
(0.84 ± 0.06) 
7.57 ± 0.04 
[n = 12; 12] 
(0.99 ± 0.06) 
The parameters shown represent the mean ± s.e.mean. The 
slopes of Arunlakshana-Schild plots were detennined by 
linear regression analysis (Tallarida et al., 1979). pAz values 
were obtaincd after tbe unity constraint bad been imposed. 
The numbers of total data points (n) and tissues used are 
given in square parentbeses. The slopes shown are not signifi-
cantly dift'erent from unity (P > 0.05), except those for (R)-1 
and (R)-4 at M 1 receptors (marked with an asterisk). 
HHSiD ""'racemic hexahydro-sila-difenidol; p-F-HHSiD-
racemic p-ftuoro-hexahydro-sila-düenidol. 
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(R)- (S)- (R)- (S)- (R)- (S)- (R)- (S)-
Hexahydro- Hexbutinol (2} Hexbutinol- p-Fiuoro-
difenidol (1) methiodide (3) hexbutinol (4) 
Fipre l Affinity profiles of the enantiomers of compounds 1-4 at 
musearlnie M 1 receptors in rabbit vas deferens (solid columns), Mz 
receptors in guinea-pig atrla (diagonally-hatehed eolumns) and M 3 
receptors in guinea-pig ileum (cross-hatched columns). 
STEREOSELECfiVITY OF MUSCARINIC RECEPTORS .ß7 
Table l Receptor selectivity and stereoselectivity [(R)/(S)] 
ratios for ehiral musearlnie antagonists 
Receptor selectivity Stereoselectivit y 
M 1/Mz MJM 1 MJMz Mt Mz M:s 
Hexahydro-difenidol (I) 
(R)-1 48 0.44 21 
550 17 191 
(S)-1 1.5 1.3 1.9 
Hexbutinol (2) 
(R)-2 10 1.0 10 
107 8.5 
(S)-2 0.81 2.5 2.0 
Hexbutinol methiodide (3) 
(R)-3 6.5 0.26 1.7 
40 17 
(S)-3 2.7 0.27 0.72 
p-Fluoro-hexbutinol (4) 
(R)-4 13 2.6 34 
34 1.7 
(S)-4 0.63 10.5 6.6 
The values shown represent the antilogs of the differences 
between corresponding mean pAz values (Table 1) deter-
mined at M 1 receptors in rabbit vas deferens as weil as at 
atrlal Mz and ileal M 3 receptors of guinea-pigs. 
44 
39 
8.5 
stallized from ethanoljdiethylether. After drying the crystals in 
vacuo, analytically pure products were obtained 
[ characterized by 1 H NMR, 13C NMR, F AB MS measure-
ments and calorimetric analysis (data not given) as weil as by 
eiemental analyses]. 
(R)-3: C21H32INO (453.4), yield 92%, m.p. 17~175°C, 
[oc]~~6 ... -3 (c = 0.5, CHC13), ee > 99.8%. Found: C, 58.3; 
H, 7.1; N, 2.9. Calculated: C, 58.28; H, 7.11; N, 3.09. (S)-3: 
C22H321NO (453.4), yield 94%, m.p. 17~175°C, [oc]~~6 = 3 (c = 0.5, CH03), ee > 99.8%. Found: C, 58.3; H, 7.1; N, 3.1. 
Calculated: C, 58.28; H, 7.11; N, 3.09. 
Results 
Twitch contractions of rabbit vas deferens elicited by electrical 
field Stimulation were inhibited by the M 1 receptor agonist, 
4-Cl-McN-A-343 (EC50 = 250nM). This effect was 
concentration-dependently antagonized by the (R)- and (S)-
enantiomers of compounds 1-4. Similarly, all Stereoisomers 
antagonized the negative inotropic responses in guinea-pig 
atria (EC50 = 7 nM) and ileal contractions (EC50 = 25 nM) of 
arecaidine propargyl ester. In the three tissues, parallel shifts 
of the agonists concentration-response curves without any 
appreciable changes of basal tension or reduction of 
maximum responses were obtained and Arunlakshana-Schild 
plots were linear through tbe concentration range tested for 
each antagonist, indicating competitive antagonism. Slopes 
(Table 1) were not significantly different from unity (P > 0.05), 
except for compounds (R)-1 and (R)-4 at M1 receptors. Tbe 
pA2 values of (R)-J and (R)-4 in rabbit vas deferens (8.71 and 
8.08, respectively; Table 1) might therefore be regarded as a 
purely experimental quantity. However, the binding affinities 
of (R)-1 and (R)-4 to M1 receptors in NB-OK 1 cells (pK1 = 
8.6 and 8.1, respectively; M. Waelbroeck, unpublished results) 
were very similar to that obtained in rabbit vas deferens 
(Table 1). In these radioligand binding studies, competition 
curves with (R)-J and (R)-4 did not deviate significantly from 
results expected for competitive inhibition of [ 3H]-N-methyl 
scopolamine ([3H]-NMS) binding. 
The (R)- and (S)-enantiomers of compounds 1-4 showed 
quite wide variations in their affinities for the musearlnie 
receptor subtypes, their pA2 values differing by more than 
three orders of magnitude (Table 1). lntroduction of a triple 
bond into the basic side chain of the parent compound 
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hexahydro-difenidol (1) (-+hexbutinol, 2), quaternization of 2 
( -+hexbutinol methiodide, 3) and p-ftuoro-substitution of the 
phenyl ring of 2 ( -+p-ftuoro-hexbutinol, 4) changed the affin-
ities of these compounds for M 1, M 2 and M 3 receptors differ-
ently. Thus compounds with qualitatively and/or 
quantitatively different receptor selectivity profiles were 
obtained (Table 2 and Figure 2). 
At each of the three musearlnie receptor subtypes, the (R)-
enantiomer of compounds 1--4 was more potent than the (S)-
configurated isomer. The difference in potencies between the 
enantiomers of compounds 1--4 was greatest at the M tt less at 
M3 and least at M2 receptors (Table 2). The degree of stereo-
selectivity (Table 2) was also dependent on the structure of the 
compounds (M 1 and M 3 : 1 > 2 > 3 > 4; M2 : 1 = 3 > 2 > 4). 
DiKussioa 
Structural variations in the (R)- and (S)-hexahydro-difenidol 
(1) molecules led to musearlnie antagonists that exhibited a 
qualitatively or quantitatively different spectrum of receptor 
selectivity to the parent Stereoisomers (R)-1 and (S)-1 (Table 2, 
Figure 2). These observed selectivities did not appear to be 
associated in generat with high affinity and absolute configu-
ration (Figure 2). For example, (S)-p-ftuoro-hexbutinol [(S)-4] 
was a relatively weak compound but it bad a novel receptor 
selectivity profile: M 3 > M 2 ~ M 1• 
The results of the present study confirm and extend pre-
vious findings that rabbit vas deferens (M 1 receptors) as weil 
as guinea-pig atria (M 2 receptors) and ileum (M3 receptors) 
possess different musearlnie receptor subtypes (Eltze, 1988; 
Eltze et al., 1988; Lambrecht et al., 1988a; Waelbroeck et al., 
1989). Furthermore, our findings provide additional evidence 
that these subtypes ean be identified on the basis of their 
stereoselectivity. There appears to be a consistent trend 
showing that the degree of stereoselectivity is always greatest 
at M 1, intermediate at M 3 and lowest at M 2 receptors (Lambrecht & Mutschler, 1986; Tacke et al., 1986; Eltze & 
Figala, 1988; Lambrecht et al., 1988b; 1989a,c,d). 
Receptor selectivity of ( R)-enantiomers 
(R)-Hexahydro-difenidol [(R)-1] was found to be a potent 
musearlnie antagonist exhibiting high affinity for M 1 recep-
tors in rabbit vas deferens as well as for M3 receptors in 
guinea-pig ileum, whereas its affinity for M2 receptors in 
guinea-pig atria was lower by factors of 48 and 21, respec-
tively (Table 2, Figure 2). The resulting affinity profile of (R)-1 
(M 1 ~ M3 > M2) is qualitatively very similar to that found 
for the racemic bexahydro-düenidol (Waelbroeck et al., 1989) 
and its racemic silicon analogue bexahydro-sila-difenidol 
(Table 1). 
The introduction of a triple bond into the (R)-hexahydro-
difenidol molecule [ -+(R)-hexbutinol; (R)-2] increased the 
affinity for M 3 and M 2 receptors by factors of 2.7 and S.S, 
respectively (Table 1), whereas the affinity for Mt receptors 
was not signifieantly different. Thus, (R)-hexbutinol shows a 
receptor selectivity profile that is qualitatively similar to that 
of tbe parent compound (R)-bexahydro-difenidol [(R)-1]. 
However, the selectivity for M 1 and M3 over M2 receptors is 
lower than tbat of (R)-1. This might be explained by differ-
ences in the electronic structures and/or the conformational 
behaviour of (R)-bexabydro-difenidol and (R)-hexbutinol. The 
triple bond in (R)-hexbutinol should make it more dißicult for 
tbis molecule to adopt the active conformation at all subtypes, 
thus creating selectivity (Barlow et al., 1988). On the other 
band, the carbon-carbon triple bond might contribute to affin-
ity and thus counteract any selectivity creating effect of rigid-
ity. 
N-methylation of (R)-hexbutinol [ -+(R)-hexbutinol methio-
dide; (R)-3] increased the affinity for Mt receptors in rabbit 
vas deferens, as weil as for M 2 receptors in guinea-pig atria by 
factors of 4.5 and 7.1, whereas the affinity for M3 receptors in 
guinea-pig ileum was not affected (Table 1). Tbus,. N-
metbylation of the tertiary amine (R)-2 cbanged the receptor 
selectivity pattern. The following affinity rank order for (R)-
hexbutinol methiodide [(R)-3] was observed: Mt> M3 ~ M2 (Figure 2). 
A comparison of the antimusearinic potencies of (R)-p-
ftuoro-hexbutinol [(R)-4] and (R)-bexbutinol [(R)-2] outlines 
the effect of ftuoro-substitution in the pbenyl ring on anti-
muscarinic potency. Tbc p-ftuoro substituent reduced the 
affinity for the muscarinic receptors up to 6 fold (Table 1 ). 
This decrease in affinity was the least pronounced at the ileal 
M3 receptors. Thus, as a result (R)-p-ftuoro-hexbutinol [(R)-4] 
showed a small preference for M3 over Mt receptors, but the 
selectivity of M3 over M2 receptors was enhanced (Table 2, 
Figure 2). 
Receptor selectivity of ( S)-enantiomers 
In general, the (S)-enantiomers of compounds 1--4 were less 
potent than the corresponding (R)-configurated isomers 
(Table 1, Figure 2). However, introduction of a triple bond 
into the hexahydro-difenidol molecule (1) as well as quater-
nization and ftuoro-substitution of hexbutinol (2) bad different 
effects on affinity for the (S)-isomers in comparison to the (R)-
enantiomers at the three musearinic receptor subtypes. Thus, 
the (S)-enantiomers showed affinity profiles which were quali-
tatively and/or quantitatively different from those obtained for 
the (R)-isomers. 
(S)-Hexabydro-difenidol [(S)-1] was a very weak muscarinic 
antagonist showing no musearinic receptor selectivity (Table 
2, Figure 2). Introduction of a tripte· bond into (S)-hexabydro-
difenidol [ -+(S)-hexbutinol; (S)-2] increased the affinity for 
M t• M2 and M3 receptors by factors of 6, 11 and 12, respec-
tively (Table 1). Thus, (S)-hexbutinol [(S)-2] showed at most a 
2 fold preference for the ileal M3 receptors (Table 2, Figure 2). 
This is different to tbe situation of the (R)-enantiomers. 
N-metbylation of (S)-hexbutinol [(S)-2] increased the aßin-
ity for M1 and M 2 receptors 12 and 3.6 fold, respectively, 
whereas the affinity for ileal M3 receptors was nearly 
uncbanged (Table 1). Thus the receptor selectivity profile of 
(S)-hexbutinol methiodide [(S)-3] is slightly different from that 
obtained for the (R)-enantiomer (Figure 2). 
Tbc inftuence of ftuoro-substitution on potency and selec-
tivity is demonstrated by comparison of (S)-hexbutinol [(S)-2] 
and (S)-p-ftuoro-hexbutinol [(S)-4] (Table 1). Compared to (S)-
2 the ftuoro derivative (S)-4 exhibited a relatively higher affin-
ity (pA2 = 7.57) for M3 receptors, whereas its antimuscarinic 
potency at M 1 and M2 receptors was lower by factors of 10.5 
and 6.6, respectively (Table 1). Thus, ftuoro-substitution in the 
para-position of the phenyl ring of (S)-hexbutinol [(S)-2] 
enhanced its M3-selectivity. The receptor selectivity profile of (S)-p-ftuoro-hexbutinol (M 3 > M2 ~ M 1) is also different from 
that of the corresponding (R)-enantiomer (M 3 ~ M1 > M2) 
and of p-ftuoro-hexahydro-sila-difenidol (M 3 > M1 > M2 ; 
Table 1). 
Stereoselectivity of muscarinic receptors 
It has been suggested (Pfeiffer, 1956) that, with greater 
potencies of drugs, larger differences in pharmacological 
effects will be seen between the enantiomers of chirat com-
pounds. The results obtained in this study (Table 1 and 2) do 
not substantiate the above suggestion and its implications 
(Lehmann, 1986). For example, at Mt receptors the affinity 
constants (pA2 values) of the more potent (R)-enantiomers 
decrease in the order (R)-hexbutinol metbiodide (9.43) > (R)-
hexbutinol (8. 78) = (R)-hexahydro-düenidol (8. 71) > (R)-p-
ftuoro-hexbutinol (8.08), whereas the stereoselectivity ratios 
[(R)/(S)] of these chirat compounds are in the order 
hexahydro-difenidol (550) > hexbutinol (107) > hexbutinol 
methiodide (40) > p-ftuoro-hexbutinol (34). Tbus, in this series 
of compounds the stereoselectivity ratio at, e.g. M 1 receptors, 
was higher by more than one order of magnitude for 
hexahydro-difenidol (1) than for hexbutinol methiodide (3), 
although compound (R)-3 was 5 fold morepotent than (R)-1. 
A similar Iack of correlation between potency of the eutomer 
and stereoselectivity ratios of enantiomers was obtained at M 2 
and M3 receptors (Tables 1 and 2). The findings of the present 
study confirm and extend previous results obtained with the 
enantiomers of biperiden (Eltze & Figala, 1988), tri-
hexyphenidyl (Lambrecht et al., 1988b; 1989d) and phenglu-
tarlmide (Lambrecht et al., 1989a). 
In 1982, Robert et al. stated a corollary of Pfeiffer's rule: 
"When different receptor subtypes interact with the enantio-
mers of chiral drugs, their stereoselectivity should increase as 
a function of affinity of the more potent enantiomer ( = eutomer; Lehmann, 1986) for the respective subtypes". 
However, when the magnitude of receptor subtype stereoselec-
tivity (difference in pA2 values of the (R)- and (S)-
enantiomers- eudismic index; Lehmann, 1986) was plotted 
against the pA2 value of the more potent isomer for that par-
ticular receptor subtype, a strong correlation (correlation coef-
ficient r = 0.995) was only observed for hexahydro-difenidol 
(Figure 3). The stereoselectivity and the affinity of the eutomer 
of hexahydro-difenidol was greatest at M 1, intermediate at M3 
and lowest at M2 receptors. On the other band the enantio-
mers of compounds 2-4 did not fulfill the predictions made by 
Robert et al. (1982). However, tbe interesting finding of this 
study is that tbe stereoselectivity ratios of all the chirat com-
pounds 1-4 consistently sbow the same order: M 1 > M3 > 
M 2 • This implies tbat tbe stereochemical demands made by 
the musearlnie receptor subtypes are different for tbe enantio-
mers of compounds 1-4 being moststringent at M 1 receptors. 
Similar results have been obtained with the enantiomers of 
telenzepine (Eveleigb et al., 1989), biperiden (Eltze & Figala, 
1988), trihexypbenidyl and its methiodide (Lambrecht et al., 
1988b) and procyclidine (Lamhrecht & Mutschler, 1986; 
Waelbroeck et al., 1988b). 
In conclusion, the present study shows that tbe anti-
musearlnie potencies and receptor subtype selectivities of the 
enantiomers of hexahydro-difenidol (1) and the acetylenic ana-
logues 2-4 (Figure 1) depend on different structural param-
eters including absolute configuration. Tbe M 1, M2 and M3 
receptors make qualitatively and quantitatively different 
stereocbemical demands for the (R)- and (S)-enantiomers, 
resulting in different receptor selectivity profiles. It is inter-
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